Summary
Gastrointestinal and ovarian malignancies frequently recur with metastatic disease limited to the abdominal cavity. Due to full thickness penetration of tumor through bowel wall, spillage of tumor from lymphatic channels by surgical trauma or perforation of the tumor through the ovarian capsule, tumor cells are disseminated throughout the peritoneal surfaces either prior to or at the time of surgical removal of the primary tumor. In the past, diagnosis of recurrent cancer was difficult because no sensitive diagnostic test was available by which to image a small tumor volume present on peritoneal surfaces. Computerized tomography with intraperitoneal infusion of contrast can demonstrate tumor nodules not otherwise detectable. Intraperitoneal installation of I-131 labeled monoclonal antibody has allowed visualization of mucinous tumor on peritoneal surfaces not seen by any other radiologic test. Intraperitoneal chemotherapy has been shown to provide palliation in patients with small volume disease confined to peritoneal surfaces. Because of limited penetration of chemotherapy into large tumor nodules this treatment strategy has not been effective for bulky intraabdominal recurrent cancer. Cytoreductive surgery utilizing high voltage electrocautery and CO2 laser evaporation of tumor can make patients relatively disease free. These surgical technologies combined with post-operative intraperitoneal chemotherapy have been shown to be of benefit for selected patients with recurrent intraabdominal cancer. The wider application of these intraperitoneal chemotherapy treatments for patients in an adjuvant setting may be of value in preventing the occurrence of peritoneal carcinosis and in improving survival.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bruijn EA de, Oosterome AT van, Jol C, Tjaden UR (1987) Intraperitoneal mitomycin in resistant ovarian cancer. Peritoneum and peritoneal access. Lund, Sweden, June 1987 (abstract)
Colcher D, Estban J, Carrasquillo JA, Sugarbaker, PH, Reynolds JC, Bryant G, Larson SM, Schlom J (1987) Completion of intracavitary and intravenous administration of monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res 47:4218–4224
Cunliffe WJ, Sugarbaker PH. Phase 1 and pharmacokinetic studies with immediate post-operative chemotherapy (in progress)
Flessner MF, Dedrick RL, Schultz JS (1985) Exchange of macromolecules between peritoneal cavity and plasma. Am J Physiol 248: H-15–H-25
Flessner JF, Fenstermacher JD, Blasberg RG, Dedrick RL (1985) Peritoneal absorption of macromolecules studies by quantitative antoradiography. Am J Physiol 248: H–26-H–32
Hughes KS, Miller DL, Neuman R, Sugarbaker PH (1988) Extrahepatic tumor deposits misdiagnosed as intrahepatic metastases. Arch Surg (in press)
Litterst CL, Torres IJ, Sikic BI (1982) Absorption of antineoplastic drugs following large volume IP administration to rats. Cancer Treat Rep 66:147–155
Piver MS, Lele SB, Marchetti DL, Baker T, Tsukada Y, Emrich LJ, McPhee ME (1987) Effect on estimated three year survival and disease free survival of optimal debulking surgery (< 2 cm residual) plus induction cis-platin (DDP) followed by PAC chemotherapy for stage III and IV ovarian carcinoma. Proc Am Soc Clin Oncol 6:111
Sugarbaker PH, Kern K, Lack E. Malignant pseudomyxoma peritonei of colonic origin: Natural history and presentation of a curative approach to treatment. Dis Colon Rectum
Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE (1985) Prospective randomized trial of intravenous intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 98: 414–421
Sugarbaker PH, Gianola FJ, Dwyer A, Neuman RN (1987) A simplified plan for follow-up of colon and rectal cancer patients is supported by prospective studies of laboratory and radiologic tests. Surgery 102:79–84
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugarbaker, P.H. Surgical management of peritoneal carcinosis: Diagnosis, prevention and treatment. Langenbecks Arch Chiv 373, 189–196 (1988). https://doi.org/10.1007/BF01274232
Issue Date:
DOI: https://doi.org/10.1007/BF01274232